Stocktoria
Dolby Laboratories, Inc. DLB
NYSE · XNYS · stock · Patent Owners & Lessors · website · IPO 2005-02-17
Dolby Laboratories, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross profit | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B |
| R&D expense | $261.8M | $263.7M | $271.5M | $261.2M | $253.6M |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M |
| Interest expense | — | — | — | $394,000 | $479,000 |
| Income tax | $47.0M | $48.2M | $48.4M | $31.4M | $36.7M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M |
| EPS (diluted) | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 |
| Operating cash flow | $472.2M | $327.3M | $367.1M | $318.6M | $447.8M |
| Free cash flow | $435.9M | $297.2M | $336.7M | $270.6M | $393.3M |
| Cash & equivalents | $701.9M | $482.0M | $745.4M | $620.1M | $1.2B |
| Inventory | $30.4M | $33.7M | $35.6M | $23.5M | $11.0M |
| Total assets | $3.2B | $3.1B | $3.0B | $2.7B | $3.1B |
| Total liabilities | $595.8M | $623.0M | $607.6M | $438.5M | $501.5M |
| Shareholders' equity | $2.6B | $2.5B | $2.4B | $2.3B | $2.6B |
Source: SEC EDGAR filings · CIK 0001308547 · as of 2025-09-26. Facts from filings plus Stocktoria's own computed scores — not investment advice.